Bifidobacterium infantis M-63: Superior Potential for Infant Use
Product description
Bifidobacterium longum subspecies infantis M-63 is unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. HMOs offer no direct nutritive value for infants, but they function in shaping a better infant gut microbiota with life-long impacts. M-63 possesses superior potential to colonize and adapt to the intestinal environment of humans, especially infants.
M-63 is considered as the probiotics strain that is well-adapted to the intestinal environment of humans, especially infants. Ingestion of M-63 is specifically effective at improving the colonization of bifidobacteria in infant gut and potentially beneficial at improving gut well-being and mental state. Contact us at [email protected] for more information.
Read more
M-63 is considered as the probiotics strain that is well-adapted to the intestinal environment of humans, especially infants. Ingestion of M-63 is specifically effective at improving the colonization of bifidobacteria in infant gut and potentially beneficial at improving gut well-being and mental state. Contact us at [email protected] for more information.
Specifications
| Categories | Probiotics |
|---|---|
| Sales markets | Asia |
| Supplied from | Japan |
| Product Applications | Dietary Supplements; Food Supplements; Healthy Food & Beverages; Infant Nutrition/ Baby Foods & Infant Formula; Pharmaceutical |
| Product Certifications | Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Kosher; Quality assurance; Sustainable Seafood; Vegan |
More products from Morinaga Nutritional Foods (Asia Pacific) Pte Ltd.
Bifidobacterium infantis M-63: Superior Potential for Infant Use
